Skip to main content

Table 4 Risk of mortality as a function of IF1 levels in coronary artery disease patients

From: Serum levels of mitochondrial inhibitory factor 1 are independently associated with long-term prognosis in coronary artery disease: the GENES Study

  Q1 Q2 Q3 Q4
(n = 147) (n = 141) (n = 145) (n = 144)
  HR (95 % CI) HR (95 % CI) HR (95 % CI)
Model 1 1 0.88 (0.59–1.32) 0.77 (0.51–1.16) 0.61 (0.39–0.94)
Model 2 1 0.90 (0.59–1.36) 0.70 (0.45–1.08) 0.54 (0.33–0.88)
Model 3 1 0.81 (0.53–1.24) 0.73 (0.47–1.12) 0.57 (0.35–0.92)
Model 4 1 1.03 (0.67–1.56) 0.77 (0.50–1.20) 0.61 (0.37–0.99)
  1. Quartiles for IF1: 0.35, 0.41, 0.49 mg/L
  2. HR (95 % CI): Hazard Ratio (95 % confidence interval)
  3. Model 1: adjusted for classical cardiovascular risk factors (age, smoking, treatments for dyslipidemia, hypertension and diabetes)
  4. Model 2: adjusted for extended cardiovascular risk factors (Model 1 + physical activity, waist circumference, HDL-C, hs-CRP and eGFR and duration of CAD)
  5. Model 3: model 2 plus NT-proBNP and hs-TnT
  6. Model 4: model 2 plus heart rate and ankle-brachial index